Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001309

Drug Information
NameFolic Acid
SynonymsKyselina listova; Acido folico [INN-Spanish]; SAM002264616; DB00158; Glutamic acid, N-(p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-, l-; Foliamin; Folacid; Folbal; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; F8758_SIGMA; Acfol (Spain); Acidum folicum; Folcysteine; C00504; Folvite; F8890_SIGMA; Folic acid (TN); SPECTRUM1502020; Prestwick3_000627; Usaf cb-13; BPBio1_000654; Kyselina listova [Czech]; Folipac; Acifolic; SPBio_001357; InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s; Folaemin; L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-; Vitamin Bc; BIDD:ER0563; BSPBio_000594; Pteroylglutamic acid; Pteroylmonoglutamate; Nifolin; (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Pteroyl-L-monoglutamic acid; HSDB 2002; SMP2_000137; Facid; KBio2_006997; MLS001335861; CID6037; Spectrum2_001459; KBioSS_001861; SMR000471860; KBio1_000494; Folcidin; CAS-59-30-3; 36653-55-1 (mono-potassium salt); F7876_SIAL; IDI1_000494; NCGC00016265-01; CHEMBL1622; Folettes; Folsav; Liver Lactobacillus casei factor; 6484-89-5 (mono-hydrochloride salt); Vitamin Be; L-glutamic acid, N-[4-[[(2-amino-4,8-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-; Folvron; Spectrum5_000602; Vitamin B11; Novofolacid [Canada]; PteGlu; Nifolin [Denmark]; Mission prenatal; Apo-Folic; LS-2157; Spectrum_001381; Folcidin (VAN); C20H20N6O6; Folsaeure; Acido folico; PGA (VAN); BIF0608; Spectrum4_001751; AKOS000503224; Folic acid [INN:BAN:JAN]; MLS001304016; Acide folique; Folina (Italy); AC1L1LNX; FOL; L-Glutamic acid, N-(4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-; KBioGR_002222; Folan; AI3-26387; Serum Folate Level; Antianemia factor; F8798_SIAL; D00070; Dosfolat B activ; Cytofol; Pteroyl-L-glutamic acid; L-Glutamic acid, N-(4-((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-; Millafol; HMS501I16; Vitamin M; Folic acid (JP15/USP/INN); Folic acid [BAN:INN:JAN]; Vitamin B9; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid; Novofolacid; Glutamic acid, pteroyl-, l-; KBio3_001558; F0043; CCRIS 666; Folico; Folasic (Australia); Folic acid dihydrate; EINECS 200-419-0; Incafolic; BIDD:GT0641; Acidum folicum [INN-Latin]; ARONIS014410; Folina; Folic; SDCCGMLS-0066738.P001; Folaemin [Netherlands]; 01769_FLUKA; Folsan; UNII-935E97BOY8; NSC 3073; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; 59-30-3; Folico (Italy); Acide folique [INN-French]; Prestwick_230; nchembio.108-comp10; Foldine [France]; MolPort-004-285-551; Folsaure; bmse000299; KBio2_001861; DivK1c_000494; Folicet; BSPBio_002338; Folacin; Folicet (TN); NINDS_000494; F7876_SIGMA; Foldine; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; HMS1921D20; CHEBI:27470; 2d0k; Pteroylmonoglutamic acid; AC-11682; CPD000471860; HMS2092N17; folic acid; Folate; Factor U; NCGC00142391-01; Spectrum3_000749; KBio2_004429; Mittafol; 33609-88-0; 4-Pteridinol, 2-amino-6-((p-((1,3-dicarboxypropyl)carbamoyl)anilino)methyl)-
IndicationFolate deficiency
[ICD9: 266.2   ICD10: D52, E53.8]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3
-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2
,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1
InChIKeyOVBPIULPVIDEAO-LBPRGKRZSA-N
Canonical SMILESC1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N    
Isomeric SMILESC1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
Therapeutic ClassVitamins
CAS NumberCAS 59-30-3
FormulaC19H19N7O6
PubChem Compound IDCID 6037.
PubChem Substance IDSID 3787.
ChEBI27470;
SuperDrug ATC IDB03BB01
SuperDrug CAS ID000059303;
TargetFolate receptorBinder[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040514 To Reference
Ref 2Gamma-glutamyl hydrolase and drug resistance. Clin Chim Acta. 2006 Dec;374(1-2):25-32. Epub 2006 Jun 10. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543